Skip to content

New Therapeutical Perspectives in Cases of Phonological Disorders

New Therapeutical Perspectives in Cases of Phonological Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02935062
Enrollment
24
Registered
2016-10-17
Start date
2016-07-31
Completion date
2018-02-28
Last updated
2019-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Speech Sound Disorders

Keywords

Speech, Speech Therapy, Speech Sound Disorders, Phonological Disorders, Auditory Perception

Brief summary

The aim of this study is to verify phonological and auditory aspects of children submitted to traditional phonological therapy, phonological therapy using a software and placebo therapy in children with phonological disorders.

Detailed description

The study will provide different therapeutic approaches for cases of phonological disorders, the classical approach would be mediated by Cycles Model, innovated approach is performed by means of an intervention speech software-SIFALA, there will still be the group that does not receive any of the proposals therapies that will be the placebo group.The study will provide 25 sessions for each group, with 30 minutes in each group. At the end of these sessions, the placebo group will receive one of the therapeutic approaches. With these three study groups, the investigators understand in what manner to obtain correct sounds is more effective.

Interventions

BEHAVIORALTraditional Phonological Therapy

Phonological therapy based on generalizing the sounds presented by figures, repetition and naming words.

BEHAVIORALSoftware Phonological Therapy- SIFALA

The phonological thearapy of this group will be based on software use with phonological model already developed, using naming and repetition of sounds.

BEHAVIORALPlacebo Therapy

No intervention to improve speech.

Sponsors

Universidade Federal de Santa Maria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 9 Years
Healthy volunteers
Yes

Inclusion criteria

* Parents/guardians and child agree to participate and have signed the Informed Consent Form; * Have age between 4:0 to 8:11 (years:months); * Present diagnosis of phonological disorders; * Present hearing thresholds within the normal range

Exclusion criteria

* Present neurological impairment, emotional and/or cognitive clearly diagnosed, or have complaint; * Present any degree of hearing loss is the type conductive, mixed or sensorineural, and middle ear disorders in time of selection, as well as having presented otitis complaints; * Present language impairment associated with speech sound disorder; * Present commitment in the stomatognathic system that can interfere in the speech production; * Have been received speech and language therapy before.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological Instrument10 weeksThe percentage of correct consonants corresponds to the number of phonemes produced by the child, evaluated initially before starting treatment and at the end of treatment. The variable of this calculation is based on the percentage which is determined at what phonological level of disorder the child is at. It is expected that at the end of treatment the percentage of correct consonants will increase due to the therapy stimuli offered.
P300- Long-latency Auditory Evoked Potential10 weeks.Electrophysiological evaluation of the auditory pathway through the protocol, Pretreatment and Post-treatment P300 waves were analyzed by the latency according to the parameters of MacPherson (1996). The electrophysiological protocol was performed before and after therapy. The marking of the waves was judged by specialist judges in the field of audiology. The variable that predicts P300 latency is quantified in milliseconds (ms

Countries

Brazil

Participant flow

Participants by arm

ArmCount
Software Phonological Therapy- SIFALA
This intervention will be intermediated by the software SIFALA. The software SIFALA, allows to select target segments using the Modelo de Estratos (second model Strata), based on the level segment of production and complexity of distinctive features, from the child's sound system analysis and planned generalizations. It also seeks the treatment of phonological disorders, by selection stimulus words in more favorable environments and playful activities with computer resource for the correct production of the target segment in the words stimulus, promoting the spread segments. Software Phonological Therapy- SIFALA: The phonological thearapy of this group will be based on software use with phonological model already developed, using naming and repetition of sounds.
8
Traditional Phonological Therapy- CYCLES
This intervention will be intermediated by the traditional model cycles. This approach has the principle of treating the suppression of operant phonological processes in child's speech, from the awareness of sound-target characteristics operating in that phonological process. Traditional Phonological Therapy: Phonological therapy based on generalizing the sounds presented by figures, repetition and naming words.
8
Placebo Therapy
No interventional group. This group will be the sham group. The proposed activities will be fun games on the computer, there is no relationship with speech and it will be not emphasized the correct sound production, will only play activities. Placebo Therapy: No intervention to improve speech.
8
Total24

Baseline characteristics

CharacteristicSoftware Phonological Therapy- SIFALATotalPlacebo TherapyTraditional Phonological Therapy- CYCLES
Age, Continuous7.81 years7.26 years6.51 years7.48 years
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants3 Participants2 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
7 Participants21 Participants6 Participants8 Participants
Region of Enrollment
Brazil
8 participants24 participants8 participants8 participants
Sex: Female, Male
Female
4 Participants10 Participants2 Participants4 Participants
Sex: Female, Male
Male
4 Participants14 Participants6 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 80 / 8
other
Total, other adverse events
0 / 80 / 80 / 8
serious
Total, serious adverse events
0 / 80 / 80 / 8

Outcome results

Primary

P300- Long-latency Auditory Evoked Potential

Electrophysiological evaluation of the auditory pathway through the protocol, Pretreatment and Post-treatment P300 waves were analyzed by the latency according to the parameters of MacPherson (1996). The electrophysiological protocol was performed before and after therapy. The marking of the waves was judged by specialist judges in the field of audiology. The variable that predicts P300 latency is quantified in milliseconds (ms

Time frame: 10 weeks.

Population: The same sample was evaluated with this P300 variable, quantified in milliseconds (ms), which corresponds to the P300 electrophysiological wave latency.

ArmMeasureGroupValue (MEAN)Dispersion
Ciclos- TherapyP300- Long-latency Auditory Evoked PotentialP300- Pre-Treatment383.60 (ms) millisecondsStandard Deviation 25.15
Ciclos- TherapyP300- Long-latency Auditory Evoked PotentialP300- Pos-Treatment344.00 (ms) millisecondsStandard Deviation 20.09
Software Phonological Therapy- SIFALAP300- Long-latency Auditory Evoked PotentialP300- Pre-Treatment373.28 (ms) millisecondsStandard Deviation 50.45
Software Phonological Therapy- SIFALAP300- Long-latency Auditory Evoked PotentialP300- Pos-Treatment362.66 (ms) millisecondsStandard Deviation 29.67
Placebo TherapyP300- Long-latency Auditory Evoked PotentialP300- Pre-Treatment357.33 (ms) millisecondsStandard Deviation 10.21
Placebo TherapyP300- Long-latency Auditory Evoked PotentialP300- Pos-Treatment353.23 (ms) millisecondsStandard Deviation 29.15
p-value: 0.011t-test, 1 sided
Primary

Percentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological Instrument

The percentage of correct consonants corresponds to the number of phonemes produced by the child, evaluated initially before starting treatment and at the end of treatment. The variable of this calculation is based on the percentage which is determined at what phonological level of disorder the child is at. It is expected that at the end of treatment the percentage of correct consonants will increase due to the therapy stimuli offered.

Time frame: 10 weeks

Population: The population is described by the age and using the variables of PCC, phonemes acquired The numbers shows the meand and standard deviation after the treatment.

ArmMeasureGroupValue (MEAN)Dispersion
Ciclos- TherapyPercentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological InstrumentPCC Pre-treatment70.63 PCC - (%)Standard Deviation 17.77
Ciclos- TherapyPercentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological InstrumentPCC Pos-treatment79.88 PCC - (%)Standard Deviation 19.86
Software Phonological Therapy- SIFALAPercentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological InstrumentPCC Pre-treatment68.13 PCC - (%)Standard Deviation 12.53
Software Phonological Therapy- SIFALAPercentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological InstrumentPCC Pos-treatment80.63 PCC - (%)Standard Deviation 14.11
Placebo TherapyPercentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological InstrumentPCC Pre-treatment75.5 PCC - (%)Standard Deviation 8.6
Placebo TherapyPercentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological InstrumentPCC Pos-treatment82.88 PCC - (%)Standard Deviation 10.68
p-value: 0.001t-test, 1 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026